longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AN2 Therapeutics

ANTX

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • AN2 Therapeutics director Robin Shane Readnour disposes of 1,108 common shares worth $6,675

    PUBT·2 days ago, 11:46 PM
    ANTX-0.18%
  • The Fringe Playbook: Finding Strategic Leverage in Niche Markets

    Global Report·Sep 9 at 10:12 AM
    INBS-0.94%ANTX-0.18%
  • Anthem (NASDAQ:ANTX) Director Robin Shane Readnour Sells 6,100 Shares of Stock

    Market Beat·Sep 9 at 01:08 AM
    ANTX-0.18%
  • AN2 Therapeutics director Robin Shane Readnour reports disposal of common shares worth $97,645.76

    PUBT·Sep 8 at 11:43 PM
    ANTX-0.18%
  • AN2 Therapeutics director Margaret M. FitzPatrick acquires 2,098 common shares worth $11,602.94

    PUBT·Sep 2 at 11:36 PM
    ANTX-0.18%
  • Anthem (NASDAQ:ANTX) Director Margaret Fitzpatrick Purchases 2,098 Shares

    Market Beat·Sep 2 at 11:08 PM
    ANTX-0.18%
  • AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting | ANTX Stock News

    StockTitan·Aug 31 at 02:00 PM
    ANTX-0.18%
  • AN2 Therapeutics names Cameron Trenor III as chief medical officer in initial beneficial ownership filing

    PUBT·Aug 27 at 06:16 PM
    ANTX-0.18%
  • AN2 Therapeutics names Cameron Trenor chief medical officer

    PUBT·Aug 24 at 11:00 AM
    ANTX-0.18%
  • AN2 Therapeutics director Robin Shane Readnour disposes of USD 212,486 common shares

    PUBT·Aug 19 at 09:59 PM
    ANTX-0.18%
  • QUICK SPARK: Russell 2000 Hits New Record Highs, Beats Nasdaq 100 In 2026

    benzinga_article·Aug 13 at 03:29 PM
    - The Russell 2000 index surpassed 3,060 points on Thursday to reach a new record high. - The small-cap index gained over 23 % year to date, outperforming the Nasdaq 100’s 19 % increase. - Top-performing stocks driving this growth include Brand Engagement Network Inc., Aehr Test Systems Inc., and AN2 Therapeutics Inc.
    AEHR-8.94%BNAI+0.25%
  • AN2 Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.

    benzinga_article·Aug 12 at 03:34 PM
    ANTX-0.18%